# Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease

> **NCT07444060** · — · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 100 (estimated)

## Conditions studied

- CD - Crohn's Disease
- Stricture; Bowel
- IBD - Inflammatory Bowel Disease

## Interventions

- **DRUG:** Guselkumab (GUS)
- **DRUG:** Ustekinumab (UST)

## Key facts

- **NCT ID:** NCT07444060
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07444060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07444060, "Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07444060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*